IQVIA HOLDINGS INC (IQV)
NYSE • Healthcare
Last close at July 2, 2026 at 20:00 UTC
Fundamentals Charts
About IQVIA HOLDINGS INC
IQVIA Holdings Inc. (NYSE: IQV) provides healthcare data, research, and commercialization services, combining technology platforms with contract research and field support for life sciences customers. In FY2025, the company generated $16.3 billion in revenue, and it operates in the medical diagnostics and research side of the healthcare sector.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
IQVIA HOLDINGS INC's Technical Indicators Summary
IQV is trading around 207 and shows a generally bullish moving-average structure with the price comfortably above most short- and medium-term averages and clear support from the 200-day level, aligning with the Buy rating. Momentum measures are strong but some oscillators are overbought, and the MACD supports upward momentum while ADX indicates a modest trend. Bollinger readings and stretched oscillators warn of near-term exhaustion even as OBV points to buying activity. Technical takeaway: strong momentum and moving-average support favor a buy stance, tempered by overbought signals.
| Indicator | Value |
|---|---|
RSI (14) | 73.42 |
Stochastic %K (14, 3, 3) | 95.71 |
CCI (20) | 206.54 |
WPR (14) | -2.71 |
Momentum (10) | 36.37 |
MFI | 68.40 |
MACD Level (12, 26) | 6.11 |
Bollinger Bands | $163.06 - $204.94 |
ATR (14) | $7.25 (3.50%) |
ADX (14) | 21.28 |
OBV | -12,322,396 |
Classic Pivot Point | $201.61 |
Fibonacci Pivot Point | $201.61 |
Exponential Moving Averages | $180.26 - $191.59(5 indicators) |
Simple Moving Averages | $173.48 - $195.40(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day wrapped with IQV preserving a mild 1.91% upside gap. By the end of the day, IQV saw below-par flow, with volume at 0.49× normal. IQV edges higher as Hardman Johnston stays firm on IQV, highlighting its data-driven pharma capabilities amid AI disruption fears.
Trading Volume
0
vs S&P 500 Today
Strong Outperformance
+4.21%
52-Week Position
Mid-range
56.8%
Updated: July 2, 2026 at 20:13 UTC